Efficient derivation and banking of clinical-grade human embryonic stem cell lines in accordance with Japanese regulations


Our master cell stocks of hESC lines may contribute to therapeutic applications using human pluripotent stem cells in Japan and other countries. © 2022 The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V.

Authors Takada K, Nakatani R, Moribe E, Yamazaki-Fujigaki S, Fujii M, Furuta M, Suemori H, Kawase E
Journal Regenerative therapy
Publication Date 2022 Dec;21:553-559
PubMed 36397823
PubMed Central PMC9647332
DOI 10.1016/j.reth.2022.10.006

Research Projects

Cell Lines